A recent review explores the potential of bacterial extracellular vesicles (BEVs) in cancer treatment and diagnosis. These naturally occurring particles can be engineered for various functions, such as drug delivery and immune system activation. However, challenges remain, including inconsistent production and safety concerns, before they can be used clinically.